Patent opinions from the Eastern District of Texas and the U.S. Court of Appeals for the Federal Circuit

Weekly Digest
Fed. Cir.

Cartessa Aesthetics, LLC v. ITC, No. 26-1582 (Fed. Cir. July 23, 2026)

Vacated & Remanded
Court
U.S. Court of Appeals for the Federal Circuit
Case No.
No. 26-1582
Decided
July 23, 2026
Judge
Per curiam
Document
Order on Motion
Length
4 pages

NOTE: This order is nonprecedential. United States Court of Appeals

for the Federal Circuit

CARTESSA AESTHETICS, LLC,

Appellant

v.

INTERNATIONAL TRADE COMMISSION,

Appellee

HYDRAFACIAL LLC, fka Edge Systems LLC,

Intervenor

2026-1582, 2026-1881

Appeals from the United States International Trade Commission in Investigation No. 337-TA-1408.

ON MOTION

Before TARANTO, CHEN, and STOLL, Circuit Judges.

O R D E R

The United States International Trade Commission (“Commission” or “ITC”) found a 19 U.S.C. § 1337 violation based on Cartessa Aesthetics, LLC’s infringement of2 Hydrafacial LLC’s patent, but suspended enforcement of an exclusion order because the patent was to expire on March 29, 2026. Following patent expiration, Cartessa moves to consolidate its appeals, dismiss them as moot, and vacate the final determination. The Commission does not oppose. Intervenor Hydrafacial LLC opposes vacatur, citing potential collateral consequences on proceedings before the United States Patent and Trademark Office (“PTO”).

“After a case (including an appeal) has been initiated, it becomes moot—and therefore no longer a ‘Case’ or ‘Controversy’ for purposes of Article III—when the issues presented are no longer ‘live’ or the parties lack a legally cognizable interest in the outcome.” Oman Fasteners, LLC v. United States, 125 F.4th 1068, 1080 (Fed. Cir. 2025) (cleaned up). In section 337 cases, this requirement generally means that an appeal is moot once the asserted patents have expired because the Commission can only grant prospective relief. See INVT SPE LLC v. Int’l Trade Comm’n, 46 F.4th 1361, 1369–70 (Fed. Cir. 2022) (collecting cases). In such situations, where mootness is due entirely to happenstance—as opposed to circumstances attributable to the parties—we have routinely vacated the Commission’s underlying final determination. See id. at 1370.

We see no sound basis to depart from that approach here. We have repeatedly rejected the argument that “the potential for collateral consequences resulting from the possible stare decisis effect of our decision” on appeal precludes mootness of appeals from the Commission involving an expired patent. Hyosung TNS Inc. v. Int’l Trade Comm’n, 926 F.3d 1353, 1359 (Fed. Cir. 2019); Tandon Corp. v. Int’l Trade Comm’n, 831 F.2d 1017, 1019 (Fed. Cir. 1987. Hydrafacial points to nothing concrete in the ongoing PTO proceedings that might suggest otherwise. It notes that the Director deinstituted review of the same patent in light of the Commission’s final determination and3 efficiency concerns1 and has more recently initiated Director review to decide whether to do the same in two matters involving related patents. But even if the Commission’s decision could serve Hydrafacial some useful benefit in such review, we cannot say such possible, indirect benefit based on independent actions by a non-party defeats mootness here.2

Accordingly,

4IT IS ORDERED THAT:

(1) The motions are granted. Appeal No. 2026-1582 and Appeal No. 2026-1881 are consolidated, and the revised official caption is reflected in this order. The appeals are dismissed as moot, the Commission’s final determination is vacated, and the case is remanded to the Commission with instructions to dismiss the investigation as moot.

(2) Each side shall bear its own costs.

FOR THE COURT

July 23, 2026

Date

Footnotes

  1. 1 Sinclair Pharma Ltd. v. Hydrafacial LLC, No. IPR2025-00145 (P.T.A.B. Feb. 12, 2026) (deinstituting review because maintaining such proceedings “when the ITC has determined that Patent Owner established commercial success and that the claims are not invalid based on the same prior art and combinations asserted in this IPR would result in significant duplication of effort, additional expense for the parties, and risk of inconsistent decisions”).
  2. 2 The cases cited by Hydrafacial in which mootness was rejected are clearly inapposite. The jurisdictional determination in Royal Brush Manufacturing, Inc. v. United States over an importer’s challenge to an evasion determination rested on the fact that such determination exposed the importer to potential civil penalties. 75 F.4th 1250 (Fed. Cir. 2023). The same cannot be said here. In Super Tire Engineering Co. v. McCorkle, the Supreme Court invoked the exception to the mootness doctrine for a controversy that is capable of repetition, yet evading review; not collateral consequences. 416 U.S. 115, 126–27 (1974). And in F.C.C. v. Fox Television Stations, Inc., 567 U.S. 239, 255 (2012), the Court merely found the Commission’s assurance that it would not impose sanctions on the broadcaster insufficient to remedy an unconstitutional policy.

Text extracted from the official PDF and reflowed for reading. It is not a certified transcript — the PDF linked above is the authoritative document.

Analysis is coming soon.

A plain-English account of the issues, facts and holding, written by Patent Case Watch. The opinion itself — its full text, its PDF and everything else on this page — stays free to read for everyone, always.

Cite this opinion

Cartessa Aesthetics, LLC v. ITC, No. 26-1582 (Fed. Cir. July 23, 2026).

Record ID
CAFC-26-1582-20260723
Permalink
https://patentcasewatch.com/opinions/CAFC-26-1582-20260723

No reporter citation is shown because the official source does not supply one; none is inferred here. Check the opinion and a citator before relying on this form.